Crinetics Pharmaceuticals(CRNX.US)

Last Updated 19:00:00 ET
longbridge loading

3 Best Healthcare Stocks to Buy in May 2026, According to Analysts

Tip Ranks·
US
CRNX
+0.69%
US
LEGN
-0.15%
US
NKTR
-1.24%
Tip Ranks·
US
CRNX
+0.69%
US
LEGN
-0.15%
US
NKTR
-1.24%

HC Wainwright Has Negative Estimate for CRNX FY2030 Earnings

Market Beat·
US
CRNX
+0.69%
US
BIB
+0.05%
US
BBH
+0.68%
Market Beat·
US
CRNX
+0.69%
US
BIB
+0.05%
US
BBH
+0.68%

Crinetics Pharmaceuticals shares are trading lower after Citizens lowered its price target on the stock from $97 to $95.

benzinga_article·
US
CRNX
+0.69%
US
IBB
+0.10%
US
BBH
+0.68%
benzinga_article·
US
CRNX
+0.69%
US
IBB
+0.10%
US
BBH
+0.68%

Crinetics (CRNX) Q1 2026 Earnings Transcript

nasdaq·
US
CRNX
+0.69%
US
LABU
-2.35%
US
XLV
+1.10%
nasdaq·
US
CRNX
+0.69%
US
LABU
-2.35%
US
XLV
+1.10%

Piper Sandler Remains a Buy on Crinetics Pharmaceuticals (CRNX)

Tip Ranks·
US
CRNX
+0.69%
US
BIB
+0.05%
US
ARKG
+0.04%
Tip Ranks·
US
CRNX
+0.69%
US
BIB
+0.05%
US
ARKG
+0.04%

Crinetics Pharmaceuticals | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 10.73 M

Earnings Watch·
US
CRNX
+0.69%
Earnings Watch·
US
CRNX
+0.69%

Jennison Associates LLC Sells 763,133 Shares of Crinetics Pharmaceuticals, Inc. $CRNX

Market Beat·
US
CRNX
+0.69%
US
BBH
+0.68%
US
PBE
+0.11%
Market Beat·
US
CRNX
+0.69%
US
BBH
+0.68%
US
PBE
+0.11%

Weekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA

rttnews·
DE
NOT
0.00%
US
NVS
+0.86%
UK
AZN
0.00%
rttnews·
DE
NOT
0.00%
US
NVS
+0.86%
UK
AZN
0.00%
© 2026 Longbridge｜Disclaimer